Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center
Add to Favorites
Medical Centers, Hospitals
1100 9th Ave, Seattle, WA 98101
206-223-6193
CLOSED NOW:
Today: 8:30 am - 5:00 pm
PHOTOS AND VIDEOS
Be the first to add a photo!
REVIEWS Write a Review
The Floyd & Delores Jones Cancer Institute at Virginia Mason provides the most advanced medical care in an environment of hope and healing.
- General Info
- Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center: As one of the preeminent cancer care providers in the United States, the Floyd & Delores Jones Cancer Institute offers the best in state-of-the-art cancer care, in a healing environment designed for patient convenience and the highest quality care Virginia Mason's cancer team diagnoses more than 2,300 new patients annually, making it one of the largest cancer centers in the Northwest. The institute achieves remarkable outcomes in its specialty areas, including the highest-volume breast reconstruction program in the Northwest and the best pancreatic cancer outcomes in the world. More than 100 clinical trials are active at any one time at the institute, providing patients with leading-edge therapies. It is also the first institution in the Northwest to utilize the daVinci robotic system to enhance cancer outcomes. The Floyd & Delores Jones Cancer Institute offers complete services for the highest level of cancer care. Areas of specialty include: * Brain Cancer * Breast Cancer * Colorectal Cancer * Esophageal Cancer * Gastrointestinal Cancer * Genitourinary Cancer * Gynecologic Cancer * Head & Neck Cancer * Lung Cancer * Pancreatic Cancer * Prostate Cancer * Thyroid Cancer * Cancer Survivorship In Seattle, call (206) 223-2374. Outside of the Seattle area, call (800) 553-7803 and ask for the Floyd & Delores Jones Cancer Institute.
- Hours
- Regular Hours
Mon - Fri: - Categories
- Medical Centers, Hospitals
- Neighborhoods
- Downtown Seattle, First Hill
Suggest an Edit
Data provided by one or more of the following: Thryv, Data Axle, Yext.